The Supplementary Effects of the Extract of Agaricus Blazei Murril on Type II Diabetes Mellitus (DM)
The purpose of this study is to examine whether the extract of the Agaricus blazei Murill mushroom is effective in the supplementary treatment of type II DM patients.
Diabetes Mellitus, Type II
Drug: Extract of Agaricus blazei Murill
|Study Design:||Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Primary Purpose: Treatment
- Percent reduction of glycated hemoglobin (HAb1C) and insulin resistance(HOMA-IR)
- Glucose, cholesterol, triglyceride, leptin, adiponectin comparisons
|Study Start Date:||July 2005|
|Study Completion Date:||December 2006|
The researchers have the animal model that the extract of the Agaricus blazei Murill mushroom is effective in the treatment of type II DM mice conducted on 2002. The dose effects were also found. The researchers conducted the pilot study also showing the same effects in 2003. So the researchers designed this trial. The elixir of the Agaricus blazei Murill mushroom is popular in Taiwan for chronic diseases, such as type II DM.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00131287
|Taipei, Taiwan, 886|
|Principal Investigator:||Hsu Chung-Hua, MD||Chinese Medicine Dep, Taipei Hospital|